Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bacillary Dysentery”

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07205926
What this trial is testing

First in Human Dose Escalation Study Evaluating the Safety and Immunogenicity of IVT's Shigella-04 Vaccine in Healthy Young Adults

Who this might be right for
ShigellaDiarrhea
Inventprise Inc. 60
Testing effectiveness (Phase 2)Study completedNCT05073003
What this trial is testing

A Study on the Safety and Immune Responses to the GVGH altSonflex1-2-3 Vaccine Against Shigellosis in Adults, Children, and Infants

Who this might be right for
Diarrhoea
GlaxoSmithKline 551
Early research (Phase 1)Study completedNCT03561181
What this trial is testing

Safety Study of S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine in Healthy Volunteers Aged Above 3 Months

Who this might be right for
DysenteryDysentery, Bacillary
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 180
Testing effectiveness (Phase 2)Active Not RecruitingNCT05182749
What this trial is testing

Safety and Efficacy of the Bacteriophage Preparation, ShigActive™, in a Human Experimental Model of Shigellosis

Who this might be right for
Shigellosis
Intralytix, Inc. 52
Early research (Phase 1)Study completedNCT02388009
What this trial is testing

Safety and Tolerability of a Bioconjugate Vaccine Against Shigella Flexneri 2a

Who this might be right for
Shigellosis
LimmaTech Biologics AG 30
Early research (Phase 1)Study completedNCT01069471
What this trial is testing

Safety and Reactogenicity of Bioconjugate Vaccine to Prevent Shigella

Who this might be right for
Shigellosis
GlycoVaxyn AG 40
Testing effectiveness (Phase 2)Study completedNCT02676895
What this trial is testing

The Safety and Immune Response of 2 Doses of a New Shigella Vaccine in Kenyan Adults

Who this might be right for
Shigella Sonnei Infection
GlaxoSmithKline 74
Large-scale testing (Phase 3)Study completedNCT00368316
What this trial is testing

Safety, Immunogenicity and Efficacy of Shigella Conjugate Vaccines in 1-4 Year Olds in Israel

Who this might be right for
Shigellosis
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 2,799
Testing effectiveness (Phase 2)Study completedNCT05121974
What this trial is testing

Tebipenem Trial in Children With Shigellosis

Who this might be right for
Shigellosis
International Centre for Diarrhoeal Disease Research, Bangladesh 132
Early research (Phase 1)WithdrawnNCT01399424
What this trial is testing

Shigella Sonnei OSPC-rDT Conjugate Vaccine

Who this might be right for
Shigellosis
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Testing effectiveness (Phase 2)Study completedNCT03527173
What this trial is testing

Evaluate the Efficacy, Safety and Immunogenicity of a Vaccine Designed to Protect Against Infection With Shigella Sonnei in Healthy Adults

Who this might be right for
Dysentery, Bacillary
GlaxoSmithKline 71
Large-scale testing (Phase 3)Active Not RecruitingNCT06838195
What this trial is testing

Clinical Trial of the S. Flexneri-S. Sonnei Bivalent Conjugate Vaccine

Who this might be right for
DysenteryDysentery, Shigella
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 8,000
Testing effectiveness (Phase 2)Study completedNCT04865497
What this trial is testing

Immunogenicity and Safety of S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine in Volunteers Aged From 3 Months to 5 Years Old

Who this might be right for
DysenteryDysentery, Bacillary
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 1,050
Early research (Phase 1)Study completedNCT01369927
What this trial is testing

Shigella Sonnel O-SPC/rBRU Conjugate Vaccine

Who this might be right for
ImmunogenicityShigellosis
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 60
Testing effectiveness (Phase 2)Looking for participantsNCT07049159
What this trial is testing

Safety, and Efficacy Study of ShigETEC, a Live, Attenuated, Oral Combination Vaccine to Prevent Shigella and ETEC Disease Delivered to Healthy Adults Ages 18 to 50 Years Old

Who this might be right for
Shigella
Eveliqure Biotechnologies GmbH 72
Early research (Phase 1)Study completedNCT02816346
What this trial is testing

Dose-Finding Study of Lyophilized Shigella Sonnei 53G Challenge Strain

Who this might be right for
Healthy
PATH 56
Early research (Phase 1)Study completedNCT00082069
What this trial is testing

Invaplex 50 Vaccine Dose-Ranging

Who this might be right for
Diarrhea
U.S. Army Medical Research and Development Command 32
Early research (Phase 1)Looking for participantsNCT05959616
What this trial is testing

Shigella Sonnei 53G Human Infection Study in Kenyan Adults

Who this might be right for
Shigellosis
University of Oxford 70
Testing effectiveness (Phase 2)Study completedNCT04602975
What this trial is testing

Investigate the Safety and Immunogenicity of the SF2a-TT15 Synthetic Carbohydrate-based Conjugate Vaccine Against Shigella Flexneri 2a

Who this might be right for
Healthy
Institut Pasteur 248
Testing effectiveness (Phase 2)Study completedNCT00800930
What this trial is testing

Therapeutic Induction of Endogenous Antibiotics

Who this might be right for
Shigellosis
International Centre for Diarrhoeal Disease Research, Bangladesh 80
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation